Literature DB >> 18200422

[Chronic Chagas disease patients with sinus node dysfunction: is the presence of IgG antibodies with muscarinic agonist action independent of left ventricular dysfunction?].

Maria Beatriz Corrêa de Mello Altschüller1, Roberto Coury Pedrosa, Basílio de Bragança Pereira, Wilson Braz Corrêa Filho, Aline Silva de Medeiros, Patrícia Cristina Santos Costa, Antonio Carlos Campos de Carvalho.   

Abstract

Studies have shown that muscarinic agonist IgG antibodies from Chagas disease patients alter the electrical activity of cardiac cells in vitro. Others have considered their presence, along with sinus node dysfunction, to be consequences of progressive cardiac lesions. The aim of this study was to evaluate the relationship between these antibodies and sinus node and left ventricular dysfunction in 65 chronic Chagas disease patients. These patients were divided into group I, composed of 31 patients with sinus node dysfunction, and group II, composed of the patients without this syndrome. Data analysis using the log linear model showed interdependence between sinus node dysfunction and the antibodies (p = 0.0021) and between nodal and ventricular dysfunction (p = 0.0005). However, no relationship was found between the antibodies and ventricular function. Age and sex did not influence any other variables. The chronic Chagas disease patients with sinus node dysfunction had higher prevalence of muscarinic agonist antibodies, independent of the presence of myocardial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18200422     DOI: 10.1590/s0037-86822007000600014

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  3 in total

1.  Enhanced parasympathetic activity in Chagas disease still stands in need of proof.

Authors:  Antonio Luiz P Ribeiro; Antonio Carlos Campos de Carvalho; Federico Lombardi; Mauro Martins Teixeira; Manoel Otávio Costa Rocha
Journal:  Int J Cardiol       Date:  2008-07-03       Impact factor: 4.164

2.  Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries.

Authors:  Joana Cortez; Rui Providência; Evelise Ramos; Cristina Valente; Jorge Seixas; Manuela Meruje; António Leitão-Marques; António Vieira
Journal:  World J Cardiol       Date:  2012-07-26

3.  Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease.

Authors:  Ana Yecê das Neves Pinto; Vera da Costa Valente; José Rodrigues Coura; Sebastião Aldo da Silva Valente; Angela Cristina Veríssimo Junqueira; Laura Cristina Santos; Alberto Gomes Ferreira; Roberto Cavalleiro de Macedo
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.